the biggest news is that RXMD revenues are steadily climbing QoQ and YoY (from $10M) to $45M while the market cap at this pps is a ridiculous $20M. In this sector the P/E ratio would give RXMD a fair value market cap of ~$200M which would be a pps of ~$40